Icon

Icon expands U.S. and U.K. bioanalytical labs

Monday, September 10, 2012 09:48 AM

Icon,a global provider of outsourced development services, is expanding its U.S. and U.K. bioanalytical facilities to meet the growing demand for biomarker and cell-based assay services.

Icon has increased its bioanalytical laboratories in Whitesboro, N.Y., and Manchester, U.K., by 7,000 and 4,000 square feet, respectively. The expansions allow Icon to house dedicated immunoassay laboratories at each facility for biomarker testing and cell-based assays.

More... »


Icon forms partnership with University College Dublin

Wednesday, September 5, 2012 10:13 AM

Icon,a global provider of outsourced development services, has entered into a strategic partnership with University College Dublin (UCD), Ireland’s largest third-level institution.

More... »


Icon to expand hospital-based presence in translational medicine

Wednesday, August 8, 2012 10:26 AM

Icon, a global provider of outsourced development services, has announced plans to further expand its U.K. hospital-based presence on the Manchester Royal Infirmary Campus.

More... »

Icon appoints three to senior clinical and laboratory positions

Tuesday, July 3, 2012 10:49 AM

Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has appointed three additions to the senior management teams of its clinical and central laboratories businesses.

More... »

Icon selects AG Mednet to give trial sponsors zero-delay efficiency

Wednesday, June 27, 2012 09:23 AM

AG Mednet has signed an OEM agreement with Icon Medical Imaging, a division of Icon, further embedding AG Mednet’s quality control, compliance, de-identification and image transfer technology into Icon’s imaging trial offerings.

More... »

ExecuPharm expands to U.K. and Argentina

Thursday, June 21, 2012 02:49 PM

ExecuPharm, a staffing and functional service providers (FSP) specializing solely in the clinical research industry, recently expanded its locations to include Europe and Latin America.

More... »

Icon makes senior appointments

Monday, May 21, 2012 11:52 AM

Icon, a global provider of outsourced development services, has appointed Dr. Susan Anton as director of epidemiology and risk management practice, Icon late phase & outcomes research, and Dr. Pui Leung as senior clinical research physician, Icon Development Solutions.

More... »

Icon reports 10% increase in Q1 2012

Wednesday, April 25, 2012 09:45 AM

Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has released its first quarter financial results for 2012, reporting its Q1 net revenues grew 10% year on year to $252.3 million from $229.3 million in Q1 2011.

More... »

ICON, Roche in technology partnership

Tuesday, March 6, 2012 01:27 PM

Global CRO ICON has been selected by Roche as its technology partner for storing and managing medical images collected during the company’s clinical research programs.

More... »

ICON reports quarterly revenue up 5%

Friday, February 17, 2012 01:43 PM

ICON,a global CRO, has reported financial results for the full year and for the fourth quarter ending Dec. 31, 2011.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs